Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 584 of 5804
-
New hope for tough prostate cancer: drug cocktail trial launches
Disease control Recruiting nowAsymptomatic patients with metastatic castrate resistant prostate cancer (mCRPC) without pain due to prostate cancer will be treated on an open label study to evaluate effectiveness of sequential treatment with the combination of difluoromethylornithine (DFMO) and high dose testo…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could changing when chemo is given boost immunotherapy for head and neck cancer?
Disease control Recruiting nowThe rationale for the new sequence of pulsed dose chemotherapy proposed in this trial is based on the hypotheses that current standard dosing of chemotherapy plus pembrolizumab ultimately suppresses the immune system and has a negative effect on the efficacy of the anti-PD-1 mono…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Spinal stimulation offers new hope for autonomic recovery after injury
Symptom relief Recruiting nowThis study is a pilot clinical trial to explore the efficacy of transcutaneous spinal cord stimulation (TCSCS) (proof-of-concept) in mitigating crucial autonomic dysfunctions that impact the health-related quality of life of individuals with spinal cord injury (SCI).
Phase: NA • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Gene-Targeted drug aims to prevent second heart attacks
Disease control Recruiting nowThis is a placebo-controlled, randomized, double-blind, parallel group, phase 3 multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic profile. Subjects will provide informed consent before any study-specific procedures are performed. A separ…
Phase: PHASE3 • Sponsor: DalCor Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo aims to keep ovarian cancer at bay
Disease control Recruiting nowThe Principal Investigator hypothesizes the combination of MIRV and Olaparib is an effective, and tolerable, maintenance therapy strategy in platinum sensitive recurrent ovarian cancer.
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Blood test could help doctors switch cancer drugs faster
Disease control Recruiting nowThis phase II trial tests how well evaluating circulating tumor deoxyribonucleic acid (ctDNA) works to guide therapy-change decisions in treating patients with triple-negative breast cancer (TNBC) that has spread from where it first started (primary site) to other places in the b…
Phase: PHASE2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can an online course cut sexual assault on campus? large trial aims to find out
Prevention Recruiting nowThe goal of this randomized trial is to test whether the Internet-Delivered Enhanced Assess, Acknowledge, Act (IDEA3) sexual assault resistance education intervention reduces sexual violence victimization in undergraduate women. Participants in the intervention group will be ask…
Phase: NA • Sponsor: University of Maryland, College Park • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
French cities launch community push to wipe out hepatitis c in drug users
Disease control OngoingThe goal of this interventional study is twofold with the evaluation of the feasibility and potential usefulness of an implementation strategy, and the efficiency of a community-based model of mass screening and immediate treatment of hepatitis C among People Who Use Drugs (PWUD)…
Phase: NA • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
New hope for rare kidney disease: iptacopan trial aims to protect kidneys
Disease control Recruiting nowThis study is designed as a multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) in idiopathic immune complex mediated membranoproliferative glomerulonephritis.
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New pill could ease severe childhood arthritis
Disease control Recruiting nowJuvenile Idiopathic Arthritis (JIA) is the most common type of arthritis that affects children. The term "idiopathic" means "of unknown origin". It is a chronic (long-lasting) disease that causes swelling, warmth, and pain of one or more small joints. Systemic JIA ia a rare and s…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New bed nets take on mosquito resistance in malaria battle
Disease control OngoingThe investigator plan to conduct a three-arm cluster-randomized control trial which compares two next generation of long-lasting Insecticidal Nets (LLINs); Veeralin®LLIN (PBO-py LLIN), Interceptor G2 (chlorfenapyr-py LLIN) to a standard py-LLIN in the department of Tiebissou Sout…
Phase: NA • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a new dosing schedule supercharge bone strength?
Disease control Recruiting nowOPTIMIST is a two-year, randomised, active controlled, open-label, multicentre intervention trial. OPTIMIST includes 3 treatment groups each comprising combinations of romosozumab (ROMO) and zoledronate (ZOL) treatment used in standard doses (210 mg monthly (sc) and 5 mg yearly (…
Phase: PHASE4 • Sponsor: University of Aarhus • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a tailored IVIg dose tame a rare nerve disorder in kids?
Disease control Recruiting nowSafety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New radiation drug targets brain tumors in kids
Disease control OngoingThe purpose of this dose finding study is to evaluate the safety and efficacy of 2 different dose levels of CLR 131 in children, adolescents and young adults with relapsed or refractory high-grade glioma (HGG).
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New immunotherapy combo aims to boost hodgkin lymphoma remission
Disease control Recruiting nowThis study is conducted to evaluate the safety and efficiency of Penpulimab combined with AVD in patients with newly- diagnosed advanced classic Hodgkin lymphoma.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for elderly leukemia patients: which chemo works best?
Disease control OngoingThe optimal induction chemotherapy regimen for newly diagnosed elderly AML patients who are eligible for intense chemotherapy is currently not well defined. Thus, we intend to conduct a multicenter, randomized, controlled clinical trial to screen the safety and efficacy of two in…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
AI eye test spots silent artery disease before it strikes
Diagnosis OngoingCardiovascular risk scores are widely used for risk stratification but may fail to identify a substantial proportion of individuals with subclinical atherosclerosis who are at increased risk of future cardiovascular events. Vascular ultrasound can directly detect carotid and femo…
Sponsor: Infanta Leonor University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
Stent may prevent deadly complications after aortic tear surgery
Disease control Recruiting nowAcute DeBakey type I aortic dissection (ATAD) is one of the most lethal surgical emergencies. The conventional operative strategy is hemiarch replacement under cardiopulmonary bypass support to replace the diseased segment of the ascending aorta. However, in patients with dissect…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Liver cancer showdown: which combo causes less harm?
Disease control CompletedThe purpose of this study is to compare the liver injury induced by HAIC combined with PD-1/PD-L1 inhibitors and TKIs versus triple therapy with TACE in the treatment of patients with advanced HCC; to compare the efficacy of the two triple therapy regimens in the treatment of pat…
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Brain-Controlled robotic hand helps stroke survivors move again at home
Disease control CompletedThe goal of this study is to define the efficacy of fully remote home-based BCI therapy in chronic hemiparetic subcortical stroke patients. A randomized controlled study using the integrated remote BCI system will be tested against standard exercise therapy to determine the effic…
Phase: NA • Sponsor: Neurolutions, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC